Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1961;9:256-263

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FINNERTY, F. A.
Right arrow Articles by TUCKMAN, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FINNERTY, F. A., JR.
Right arrow Articles by TUCKMAN, J.
(Circulation Research. 1961;9:256.)
© 1961 American Heart Association, Inc.


Evaluation of the Pressor, Cardiac, and Renal Hemodynamic Properties of Angiotensin II in Man

FRANK A. FINNERTY JR. M.D.1, GLORIA DECARLO MASSARO M.D.2, VICTOR CHUPKOVICH M.D.2, JOHN TUCKMAN M.D.2

1 Department of Medicine, Georgetown University School of Medicine, and the Georgetown Medical Division of the District of Columbia General Hospital, Washington, D. C.
2 Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden

These data demonstrate that in normal subjects angiotensin II is 10 times as potent as norepinephrine, which it resembles hemodynamically. An increase in the systolic pressure is associated with significant increase in diastolic pressure, increase in venous pressure, decrease in heart rate, slight decrease in cardiac output with striking increase in total peripheral resistance, decrease in renal blood flow, decreased glomerular filtration rate, increase in filtration fraction, arid slight decrease in urinary volume.

Preliminary studies of patients in shock suggest that angiotensin II is two or three times as potent as norepinephrine. Continuous administration is not associated with the development of resistance or tachyphylaxis, nor does sloughing of tissues occur when there is leakage outside the vein.

Submitted on August 23, 1960




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
W. W. SPINK
Endotoxin Shock
Ann Intern Med, October 1, 1962; 57(4): 538 - 552.
[Abstract] [PDF]